RICHARD A. DAVIS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2002-04-29 Richard A. Davis Age: 66 Director. Mr. Davis has retired as President and Chief Executive Officer of Pentzer Corporation, a private investment company and subsidiary of AVISTA Corp. ... He has served as an advisor to the Washington State Investment Board, served on the Board of Regents for Washington State University and the Washington Technology Alliance Board, as Chairman of the Association of Washington Business, and has served on the boards of several medical diagnostic companies. ... Member of Audit and Compensation Committees; Mr. Wolf was appointed to the Audit and Compensation Committees on April 8, 2002.
2003-04-30 Richard A. Davis Age: 67 Director. Mr. Davis has retired as President and Chief Executive Officer of Pentzer Corporation, a private investment company and subsidiary of AVISTA Corp. ... Members of this committee are Richard A. Davis, Stuart S. Lang, Tom Wolf, and William G. Pryor, who assumed his committee membership in November 2002 when he was appointed to the Board. He is also a member of the Audit Committee. ... The Company pays an annual fee of $4,000 to each non-employee director and an additional $1,000 to non-employee directors for serving as committee chair. During 2002, OXIS did not make payments under this policy. Payments will resume in 2003.
2004-04-29 Richard A. Davis Age: 68 Director. Mr. Davis served as President and Chief Executive Officer of Pentzer Corporation, a private investment company and subsidiary of AVISTA Corp. from 1990 until his retirement in 2001. ... The Company pays an annual fee of $4,000 to each non-employee director and an additional $1,000 to non-employee directors for serving as committee chair. ... After the resignations of Messrs. Ford Webb and Pryor, the Board appointed Dr. Bruinsma and Dr. Ferris as new members of this Committee, such that the Committee is currently comprised of Mr. Davis (Chair), Dr. Bruinsma and Dr. Ferris.

Data sourced from SEC filings. Last updated: 2025-08-30